Clinical Trial Detail

NCT ID NCT02553460
Title Total Therapy for Infants With Acute Lymphoblastic Leukemia (ALL) I
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements no
Sponsors St. Jude Children's Research Hospital
Indications

acute lymphocytic leukemia

Therapies

Cyclophosphamide

Mitoxantrone

Dexamethasone

Bortezomib

Etoposide

Vincristine

Pegaspargase

Vorinostat

Cytarabine

Methotrexate

Leucovorin

Age Groups: child

No variant requirements are available.